Throughout her career, Helen demonstrated an unwavering commitment to evidence, science, and truth, helping the public understand some of the most complex and consequential health challenges of our time.
email to STAT
“At a moment when misinformation competes with facts, her reporting was a trusted source of clarity, honesty, and insight.”
“Novartis now expects to speak with the FDA about a potential accelerated approval of pelabresib before the end of the year, CEO Vas Narasimhan told investors on a call Tuesday.”
“The industry has gotten more consolidated. Prices are higher than ever. Access is worse than ever.”
“The rising costs are unsustainable for individuals, for businesses, and for the country. What kind of intervention is a different question.”